National Arthritis Meeting 20042004 Meeting of The American College of Rheumatology


Dr. Shiel, Editor of MedicineNet's Arthritis Overview, Offers Perspectives Of Interest On Topics From 2004 Annual Scientific Meeting of The American College of Rheumatology (held October 16-21, 2004)

Dr. Shiel  at  the  Annual  Scientifc Meeting Of The American College Of Rheumatology It is critical to the health of patients with arthritis that such important research is occurring. Arthritis alone currently affects 15% of all Americans and the number affected will grow to 18.2% by the year 2020. It has dramatic effects on the function and well-being of hundreds of millions of people worldwide.

I want to highlight for you many of the reports and papers that led to my own excitement as they clearly are going to have an impact on the general public health.

Here, I will summarize reports on a variety of arthritis and rheumatism topics that I know you will find interesting. Click on each item from the Disease Index below for the summary of my coverage for that particular arthritis or rheumatism topic.

I hope you enjoy these reports! - Dr. Shiel

Reports From National Meeting Disease Index

Ankylosing Spondylitis and Psoriatic Arthritis - Powerful new treatments reviewed (Remicade, Enbrel, and others). - Real research evaluating these potentially devastating forms of arthritis that affect 0.21% of Americans over age 15. Not uncommon forms of chronic pain in younger people.

Arthritis Drugs & New Medications - What's new, what's old, what's safe, what's not (Vioxx), what's coming.

Drug Withdrawn - Vioxx, A Perspective After National Arthritis Meeting - Vioxx, a drug that has been used to quiet inflammation of arthritis and relieve pain, was withdrawn from the market by its maker, Merck, on September 30, 2004.